N1 Technologies Requests Patent of Bacteriophage to Treat Antibiotic-Resistant Pneumonias
N1 Technologies recently announced that the company has filed a biotech patent with the United States Patent and Trademark Office (USPTO) for its Viritron VPN, an in-development bacteriophage treatment for patients with pneumonia. ... Read more